SONABLATE
High-Intensity Focussed Ultrasound (HIFU) for targeted Therapy of Prostate Carcinoma
Description

Earlier, precise diagnostic of prostate cancer demands a paradigm change respectively a new treatment pathway.

SONABLATE HIFU is the image-guided, non-invasive surgical ablation system that delivers precise, focused and controlled ablative energy and allows to create a customized treatment for each patient’s individual prostate needs.

High-intensity focused ultrasound energy is transmitted through the rectal wall and focused at desired locations within the prostate, identified by MRI and confirmed by fusion with real-time ultrasound. At the focal point of these sound waves, tissue temperature rapidly rises to almost 90 degrees Celsius, destroying the targeted tissue while surrounding tissue remains unharmed.

SONABLATE features integrated imaging and ablation transducers that are allowing to AIM, ABLATE, and ANALYZE the results of the treatment:

  • AIM at specific tissue using real-time ultrasound imaging and the MRI-US fusion SonaFuse, the licensed and validated integration of established fusion biopsy platforms into the SONABLATE planning software.
  • ABLATE with pinpoint accuracy and adjustment for each individual dose of HIFU while sparing untargeted tissue. 
  • ANALYZE procedure results using real-time imaging and advanced, patented Tissue Change Monitoring (TCM) Technology.

 

Advantages 

 

  • Licensed MRI/US fusion from original fusion biopsy providers for high precision of the treatment
  • Adjustable for each single dose of HIFU energy
  • Enable to response individually to the patient’s prostate tissue reaction
  • Non-invasive, bloodless ablation
  • Healthy tissue sparing
  • Low side effects Repeatable procedure, if indicated
  • Radiation-free
  • Cost efficient
Components
The Probe

The Sonablate probe delivers precise and focused ablative energy into the prostate. Various planning and control functions allow an individually adapted treatment of the prostate.

The Sonasource

The Sonasource console powers the Sonablate probe. It is comprised of several integrated programmable hardware and software modules that are used to drive and control SonaCare Medical's probes.

Also included with Sonasource is Sonachill, a water degasser, cooler and circulator used to ensure temperature stabilization and acoustic coupling.

Sonablate Disposable Kit

It is comprised of a sterile probe tip pack and a water path kit. The probe tip allows sterile patient contact required for acoustic coupling between the target tissue and energy source.

SonaFuse

The HIFU fusion platform follows an open architecture approach for the validated integration of existing mpMRI fusion biopsy platforms into the Sonablate planning software.

Segmented and annotated MRI images are imported into Sonablate and merged with live ultrasound images.

Sonablate Safety Features

Features such as Tissue Change Monitoring (TCM), Total Acoustic Power (TAP), Reflexivity Index Monitor (RIM) and others enable the surgeon to respond individually to the patient's prostate and form the basis for successful, sustainable results with fewer side effects.

SELECTED PUBLICATIONS
June 2018
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
S. Guillaumier, M. Peters, M. Arya, N. Afzal, S. Charman, T. Dudderidge, F. Hosking-Jervis, R. G. Hindley, H. Lewi, N. McCartan, C. M. Moore, R. Nigam, C. Ogden, R. Persad, K. Shah, J. van der Meulen, J. Virdi, M. Winkler, M. Emberton, H. U. Ahmed: A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol. 2018 Oct;74(4):422-429. doi: 10.1016/j.eururo.2018.06.006. Epub 2018 Jun 28.
April 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer
A. Kanthabalan, M. Peters, M. Van Vulpen, N. McCartan, R. G. Hindley, A. Emara, C. M. Moore, M. Arya, M. Emberton and H. U. Ahmed: Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer. BJU Int. 2017 Aug;120(2): 246-256. doi: 10.1111/bju.13831. Epub 2017 Apr 3.
July 2014
Improved Outcomes with Advancements in High Intensity Focused Ultrasound Devices for the Treatment of Localized Prostate Cancer
Toyoaki U, Tetsuro T, Hakushi K, Mayura N, Sunao S, Yoshihiro N and Toshiro T: mproved Outcomes with Advancements in High Intensity Focused Ultrasound Devices for the Treatment of Localized Prostate Cancer. J Urol. 2015 Jan;193(1):103-10. doi: 10.1016/j.juro.2014.07.096. Epub 2014 Jul 28.
Learn more on:
sonacaremedical.com
We take our time with you
We look forward to getting in touch with you
Thank you for your inquiry. We will answer you as soon as possible.
This site uses cookies to improve your user experience. You may find out more about in our Privacy Policy. By using this website you accept our use of cookies.
OK